Reduced body clearance as the major mechanism of the potentiation by beta2-adrenergic agonists of paraquat lethality in rats.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D003864:Depression, Chemical; D004357:Drug Synergism; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008168:Lung / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D010269:Paraquat / Q000378:metabolism / Q000633:toxicity*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism; D013997:Time Factors; D014018:Tissue Distribution
D000318:Adrenergic beta-Agonists; D011433:Propranolol; D007545:Isoproterenol; D010269:Paraquat